Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthrax.

M Mock1, A Fouet

  • 1Toxines et Pathogénie Bactérienne, (CNRS URA 2172), Institut Pasteur, Paris Cedex 15, France. mmock@pasteur.fr

Annual Review of Microbiology
|September 7, 2001
PubMed
Summary
This summary is machine-generated.

Bacillus anthracis causes anthrax, with its virulence linked to toxins and a polyglutamic capsule. Understanding these factors aids in developing safer vaccines for veterinary and human use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parvalbumin- and vasoactive intestinal polypeptide-expressing neocortical interneurons impose differential inhibition on Martinotti cells.

Nature communications·2016
Same author

Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.

Medecine et maladies infectieuses·2015
Same author

Group B streptococcus neonatal invasive infections, France 2007-2012.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same author

[Epidemiology of Streptococcus pyogenes invasive diseases in France (2007-2011)].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2014
Same author

Identification of CodY targets in Bacillus anthracis by genome-wide in vitro binding analysis.

Journal of bacteriology·2013
Same author

Therapeutic recommendations for the management of patients exposed to Bacillus anthracis in natural settings. SPILF. Société de pathologie infectieuse de langue franc¸aise .

Medecine et maladies infectieuses·2011
Same journal

Circadian Control of Host-Microbiome Symbioses.

Annual review of microbiology·2026
Same journal

Host-Pathogen Interactions in Malaria: Invasion, Neutralization, and Evasion.

Annual review of microbiology·2026
Same journal

From an Interest in Molecules to a Fascination with Microbes.

Annual review of microbiology·2026
Same journal

Bacterial Physiology in the Context of Algal Partners.

Annual review of microbiology·2026
Same journal

Introduction.

Annual review of microbiology·2025
Same journal

Decoding Microbial Community Assembly: Insights on Vectors of Infectious Diseases.

Annual review of microbiology·2025
See all related articles

Area of Science:

  • Medical microbiology
  • Bacterial pathogenesis
  • Vaccine development

Background:

  • Bacillus anthracis identified as the cause of anthrax in the late 19th century.
  • Key medical microbiology concepts stem from early research on this bacterium.
  • Plasmids and major virulence factors of B. anthracis were linked in the 1980s.

Purpose of the Study:

  • To review the structure-function analysis of B. anthracis toxins.
  • To discuss the role of the polyglutamic capsule in virulence.
  • To explore the phylogenetic placement of B. anthracis within the Bacillus cereus group.

Main Methods:

  • Structure-function analysis of toxin components.
  • Review of B. anthracis phylogeny.
  • Examination of capsule and S-layer composition.

Related Experiment Videos

Main Results:

  • B. anthracis possesses two A-B type toxins and an antiphagocytic polyglutamic capsule.
  • Toxin B-domain binds to cell receptors and forms a heptamer; enzyme moieties include adenylate cyclase and a metalloprotease.
  • Capsule is supported by an S-layer of two distinct proteins.

Conclusions:

  • Knowledge of B. anthracis toxins aids in designing safer veterinary vaccines.
  • Spore-structure analysis may improve human nonliving vaccines.
  • Phylogenetic review places B. anthracis within the Bacillus cereus group.